
This retrospective cohort study compared long-term health expenditures between patients with diabetes undergoing Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). Over 5.5 years post-surgery, total expenditures significantly decreased for both groups, primarily due to reduced pharmacy costs. No significant differences in overall costs were observed between RYGB and SG, except for transiently higher inpatient expenditures in the RYGB group during the first six months.
Like
Save
Share